BioNTech SE American Depositary Share (0A3M)
LSE
Closed
Oct 7, 2026
Day's Range
93.9152 wk Range
79.51Overview - 0A3M - BioNTech SE American Depositary Share
Key Statistics
Valuation
Enterprise Value
7.39B
P/E (Trailing)
‪5.49‬
P/E (Forward)
‪5.48‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪2.96‬
Price / Book
‪1.19‬
EV / EBITDA
‪1.09‬
Profitability
Gross Margin
‪8.14%‬
Profit Margin
‪47.64%‬
Operating Margin
‪63.94%‬
Return on Assets
‪16.92%‬
Return on Equity
‪23.82%‬
Ownership
Shares Outstanding
251.20M
Float
86.11M
Held by Insiders
‪65.11%‬
Held by Institutions
‪17.59%‬
Price stats
Beta
‪0.24‬
50-Day Avg
‪97.94‬
200-Day Avg
‪97.58‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Monthly
Market Cap - 0A3M - BioNTech SE American Depositary Share
Peers - 0A3M - BioNTech SE American Depositary Share
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0A3MLSEBioNTech SE American Depositary Share27.16BMarket Cap+0.00%52-week change5.50P/E (Trailing)‪47.64%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0A3M - BioNTech SE American Depositary Share
About
BioNTech SE American Depositary Share is the U.S.-traded depositary share of BioNTech SE, a Germany-based biotechnology company focused on immunotherapy and vaccines. The company develops cancer therapeutics, including individualized treatment approaches such as personalized immunotherapies, and also works on vaccines…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
